Bullish Case: CLVT at $1.605 has arguably priced distress: P/B ~1.1, sticky subscription revenue, positive operating income, and active deleveraging. The Helium PDF puts peak density near $1.50-2.00 with a fat right tail, and the Apr-2027 $2.50C ($99.6 IV, delta 0.40) shows call-side demand for a >50% rebound. AI-product momentum (Nexus Connect, Web of Science assistants) plus a Q3 beat could trigger a sharp mean-reversion pop from deeply oversold levels.

Bearish Case: Backwardated IV (349% at Oct-17 falling to ~105% at Apr-17) signals markets fear near-term ruin — effectively a credit-style event window. The return-surface likelihood mass clusters at severe losses (-50% to -85%), the stock is -76% over two years and still falling (-33% in 90 days), and the Helium AI forecast is -1.78%. Churn, ACV stagnation, or covenant/liquidity stress could push shares toward $0.50-1.00 where put density sits.

Potential Outcomes:

• 35% Distress drift lower: $1.00–1.50 by Dec; IV stays backwardated.
• 25% Continued slide to $0.50–1.00; near-expiry puts bid (500% IV).
• 20% Oversold rebound to $2.00–2.50 on Q3 beat/FCF print; Nov-Dec calls pay off.
• 10% Vol spike, price sideways $1.40–1.80.
• 7% Restructuring/deal announcement; wide dispersion, puts/calls both reprice.
• 3% Macro (SPY shock) tail amplifying downside.

October 15, 2026